5q- syndrome
WikiDoc Resources for 5q- syndrome |
Articles |
---|
Most recent articles on 5q- syndrome Most cited articles on 5q- syndrome |
Media |
Powerpoint slides on 5q- syndrome |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on 5q- syndrome at Clinical Trials.gov Clinical Trials on 5q- syndrome at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on 5q- syndrome
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on 5q- syndrome Discussion groups on 5q- syndrome Patient Handouts on 5q- syndrome Directions to Hospitals Treating 5q- syndrome Risk calculators and risk factors for 5q- syndrome
|
Healthcare Provider Resources |
Causes & Risk Factors for 5q- syndrome |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
5q- syndrome is a rare disorder caused by loss of part of the long arm (q arm, band 5q31.1) of human chromosome 5. This syndrome affects bone marrow cells, causing treatment-resistant anemia, and myelodysplastic syndromes that may lead to acute myelogenous leukemia. Examination of the bone marrow shows characteristic changes in the megakaryocytes. They are more numerous than usual, small and mononuclear. There may be accompanying erythroid hyperplasia.
Lenalidomide is a new agent that is showing promise in treating 5q- syndrome.